Sanofi Extends, Revamps Discovery Pact With Warp Drive
This article was originally published in Scrip
Executive Summary
Sanofi SA has extended and revamped its existing discovery pact with Warp Drive Bio - a move that increases chances the French group will buy the Boston-based biotech if they successfully use its two computational platforms to find new oncology drugs and antibiotics based on natural products.